SB 609: Controlled substances: narcotic replacement treatment.
- Session Year: 2015-2016
- House: Senate
- Latest Version Date: 2015-04-21
Existing law specifies the controlled substances that may be used in narcotic replacement therapy by licensed narcotic treatment programs, including federally approved controlled substances used for the purpose of narcotic replacement treatment, and requires the State Department of Public Health to establish guidelines for narcotic treatment programs, including dosage requirements.
This bill would, instead, authorize the use of federally approved controlled substances used for the purpose of substance use disorder treatment.
Existing law, the Communicable Disease Prevention and Control Act, imposes various functions and duties on the State Department of Public Health and local health officers with respect to the prevention and control of communicable diseases. The act provides that a health officer includes county, city, and district health officers, and city and district health boards, but not advisory health boards.
This bill would make a technical, nonsubstantive change to this provision.
Existing law, the Communicable Disease Prevention and Control Act, imposes various functions and duties on the State Department of Public Health and local health officers with respect to the prevention and control of communicable diseases. The act provides that a health officer includes county, city, and district health officers, and city and district health boards, but not advisory health boards.
This bill would make a technical, nonsubstantive change to this provision.
The following controlled substances are authorized for use in narcotic replacement therapy by licensed narcotic treatment programs:
(a)Methadone.
(b)Levoalphacetylmethadol (LAAM) as specified in paragraph (10) of subdivision (c) of Section 11055.
(c)Buprenorphine products or combination of products approved by the federal Food and Drug Administration for maintenance or detoxification of opioid dependence.
(d)Any other federally approved, approved controlled substances used for the purpose of narcotic replacement substance use disorder treatment.
SECTION 1.Section 120100 of the Health and Safety Code is amended to read:120100.Health officer, as used in the Communicable Disease Prevention and Control Act as set forth in Section 27, includes county, city, and district health officers, and city and district health boards, but does not include advisory health boards.
Health officer, as used in the Communicable Disease Prevention and Control Act (Section 27) as set forth in Section 27, includes county, city, and district health officers, and city and district health boards, but does not include advisory health boards.
|
Date
|
Status
|
|---|---|
| Feb 27, 2015 | Introduced. To Com. on RLS. for assignment. To print. |
| Mar 2, 2015 | From printer. May be acted upon on or after April 1. |
| Mar 2, 2015 | Read first time. |
| Mar 12, 2015 | Referred to Com. on RLS. |
| Apr 21, 2015 | From committee with author's amendments. Read second time and amended. Re-referred to Com. on RLS. |
| May 14, 2015 | Re-referred to Com. on HEALTH. |
| Feb 1, 2016 | Returned to Secretary of Senate pursuant to Joint Rule 56. |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
Bill Author
Bill Co-Author(s):